Ocrelizumab dosage and usage

Ocrelizumab is a monoclonal antibody used to treat multiple sclerosis (MS). Its administration method and dosage must strictly follow relevant guidelines.

Premedication is recommended before infusion of ocrelizumab. 100 mg of prednisolone (or equivalent corticosteroid) should be administered intravenously approximately 30 minutes before each infusion to reduce the frequency and severity of infusion reactions. In addition, patients can take an antihistamine (such as diphenhydramine) 30 to 60 minutes before the ocrelizumab infusion to further reduce the risk of infusion reactions. At the same time, you can also consider using fever-reducing drugs (such as acetaminophen) to reduce possible uncomfortable symptoms.

Ocrelizumab is administered by intravenous infusion, and patients need to be observed for at least one hour after the infusion is completed. The injection of this drug is in a solution state and is injected intravenously by a doctor or nurse. In the initial treatment phase, the first and second doses (at weeks 0 and 2 respectively) are both 300 mg, and the injection time is usually maintained at least 2.5 hours. After that, patients need to receive an intravenous infusion of 600 mg every 6 months, with the entire infusion lasting approximately 2 to 3.5 hours.

It’s important to note that while ocrelizumab works well at controlling the symptoms of multiple sclerosis, there is currently no cure for the disease. Therefore, patients should communicate with their doctors regularly during treatment in order to promptly evaluate the effect of the drug and adjust the treatment plan.

If a patient misses a scheduled infusion of ocrelizumab, a makeup injection should be scheduled as soon as possible without waiting for the next scheduled dose. Especially after missed doses for more than 6 months, the dosing schedule needs to be reset to continue treatment, while ensuring that there is at least 5 months between each dose.

In general, the usage and dosage of ocrelizumab must be strictly in accordance with the doctor's instructions to ensure the best therapeutic effect and safety. Patients should pay close attention to their own reactions during treatment and provide timely feedback to the medical team to promote better health management.

Reference materials:https://www.ocrevus.com/